The U.S. Food and Drug Administration granted approval of a drug that is the first immunotherapy treatment indicated for patients diagnosed with advanced basal cell…
We discuss “Smart” Natural Killer Cells for Cancer Treatment, Sonny Hsiao of Acepodia. A clinical trial targeting HER2-expressing solid tumors with “smart” NK cells.…
An Erasmus MC biotech venture spin-off was announced recently in Rotterdam, Netherlands. Pan Cancer T B.V., founded by Prof. Dr. Reno Debets (CSO) and Dr.…
The National Institutes of Health awarded $4 million to Memorial Sloan Kettering Cancer Center (MSKCC) and the City College of New York (CCNY) to study…
A group of 37 medical and radiation oncologists, along with a robust staff of cancer care providers, led by Drs. Bruno S. Fang and Edward…
A prominent non-government funder of childhood research grants, the St. Baldrick’s Foundation, formalized a partnership with the Dallas, Texas, based TeamConnor Childhood Cancer Foundation. Combined…
Shanghai China-based Junshi Biosciences (HKEX: 1877; SSE: 688180) announced the biotech venture received Fast Track designation by the U.S. Food and Drug Administration (FDA) for…
Hoag Memorial Hospital Presbyterian is on the move, building what will become an elite Molecular Imaging and Therapy program. Based on the vision of Dr.…
Five Prime Therapeutics (NASDAQ: FPRX) in partnership with Zai Lab Ltd. (Shanghai, China) recently shared the results of the global, randomized, double-blind placebo—controlled Phase 2…
A novel website called Cancertrialsearch.com intelligently matches patients with gastrointestinal cancers to clinical trials based on seven (7) criteria supporting the patient (or loved ones) in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
